Bitcoin traded near $77,900 as crypto futures volume surged 56% to $111.8 billion, while open interest remained steady at $137.1 billion, indicating more trading activity without new positions. Liquidations rose 77% to $140.2 million, and the most traded Bitcoin options were puts. Meanwhile, U.S. spot Bitcoin ETFs experienced $643 million in net outflows on Friday, marking their largest single-day withdrawal since June after four days of inflows. This suggests increased market volatility and cautious investor sentiment.
Bitcoin trading near $77,900 provides context for this report on crypto futures volume. For readers following the cryptocurrency market, here is Pluang's market snapshot as of Nov 02, 2026 19:42 WIB: out of 50 major cryptocurrencies priced on Pluang, 7 rose and 42 fell. Notable movers include AAVE at Rp2.388.769 with a 1-day change of -4.02% and a Pluang order activity split of 72% Sell / 28% Buy, ONE at Rp20 with -3.91% and 42% Sell / 58% Buy, and EGLD at Rp60.408 with -3.71% and 95% Sell / 5% Buy. Typical hold times on Pluang range from 86 to 154 days among these assets.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...
Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...
